EuropeThe EU Commission strikes again – Ne...In times of the pandemic it was called to ban patents that are related to Covid-19 vaccines, medicaments, and diagnostics and the European Parliament was in favour of it. Now there is a call from the … more ➔
Biotech ClusterPaving the way to internationalisation Due to the global niche character of pharmaceutical biotechnology, research collaborations and market entries on an international level are essential. Agility and market knowledge are required to … more ➔
Drug developmentDerisking drug programs by early lead opti...Antibody engineering?The development of therapeutic antibodies is a time and cost intensive process. Biological and physicochemical properties of the lead molecules influence almost every step in … more ➔
CDMONavigating the CDMO proposal processWhen businesses receive a proposal from a contract development and manufacturing organisation (CDMO), it’s much like a first date: first impressions matter. The proposal process not only reveals a CDMO’s … more ➔
Central LaboratoriesChallenges in the central labClinical trials have to be coordinated as a safe process where monitoring, analytics and handling of patient samples is streamlined – even cross oceans. German MLM Medical Labs is quickly establishing … more ➔
BiomanufacturingManufacturing Biopharmaceuticals Within the competitive CDMO market, Richter-Helm has developed into a highly valued partner when it comes to the manufacturing of biopharmaceuticals. Richter-Helm is well recognised by pharmaceutical … more ➔
BerlinInfrastructure makes the difference A well connected and effective infrastructure, a high density of research and development as well as close networking are of great value, not only to founders. Within the successful healthcare cluster … more ➔
Biobank, personalised medicinePrecision therapeutics: optimising early d... Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing … more ➔
SpainSpain: An overview over a sector that has...After two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech companies has stabilised, and they face significant challenges, positioning biotechnology as a … more ➔
Artificial intelligenceAI – tool or trouble? Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, … more ➔
